Mulhouse, France

Brian Peter Richardson

This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian Peter Richardson. Retrieved from https://idiyas.com/inventor/brian-peter-richardson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brian Peter Richardson: Innovator in Metabolic Disorder Treatments

Introduction

Brian Peter Richardson is a notable inventor based in Mulhouse, France. He has made significant contributions to the field of metabolic disorders through his innovative research and development.

Latest Patents

Richardson holds a patent for a method for treating metabolic disorders by the administration of an anti-ActRIIB antibody. This invention relates to compositions comprising anti-ActRIIB antibodies and their use for increasing brown fat in vertebrates, including rodents and primates, particularly in humans, without significantly affecting hematological parameters. He has 1 patent to his name.

Career Highlights

Richardson is currently associated with Novartis AG, a leading global healthcare company. His work focuses on advancing treatments that can improve metabolic health and address related disorders.

Collaborations

He has collaborated with notable colleagues, including Jerome Feige and David Jonathan Glass, to further enhance the impact of his research.

Conclusion

Brian Peter Richardson's innovative work in the treatment of metabolic disorders showcases his commitment to advancing medical science and improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…